Silexion Therapeutics Corp Ordinary Shares (SLXN) is a publicly traded Healthcare sector company. As of September 21, 2026, SLXN trades at $0.49 with a market cap of $2.42M and a P/E ratio of 0.01. SLXN moved +10.36% today. Year to date, SLXN is -97.73%; over the trailing twelve months it is -98.79%. Its 52-week range spans $0.32 to $517.50. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces SLXN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for SLXN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.49 |
| Market Cap | $2.42M |
| P/E Ratio | 0.01 |
| EPS | $26.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $517.50 |
| 52-Week Low | $0.32 |
| Volume | 4.01M |
| Avg Volume | 0 |
| Revenue (TTM) | $28.00K |
| Net Income | $-16.52M |
| Gross Margin | 0.00% |
1 analysts cover SLXN: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.